Mark Smith
PFD Report
All Responded
Ref: 2025-0478
All 1 response received
· Deadline: 19 Nov 2025
Coroner's Concerns (AI summary)
The GP practice lacked a system or policy to ensure appropriate medication reviews for vulnerable patients with addiction or self-harm history, risking stockpiling and misuse of prescribed drugs.
View full coroner's concerns
Evidence was received from two GP Partners at Mr Smith’s GP Practice. Both GPs confirmed that at the time of Mr Smith’s involvement with the Practice continuing up to and including the date of the inquest, there continued to be no system, policy or process in place, to ensure that vulnerable patients with a history of addiction and/or self-harm and/or suicidal ideation and/or prescription medication overdose received or receive appropriate medication reviews to consider the frequency and volume of repeat prescribed medication. It was conceded, accordingly, that there was - and remained - no policy or procedure in place to mitigate the clear risk involved in GPs prescribing unnecessarily excessive quantities of (potentially dangerous) prescription medication (at inappropriate frequency) to a clearly vulnerable cohort of patients, and therefore no policy or procedure is in place to minimise the danger of stockpiling of such medications and the concomitant risk of potentially fatal, (advertent or inadvertent), misuse of such medication.
Responses
Action Taken
Addison House Health Centre has reviewed and updated its prescribing policy, enhanced IT system alerts related to self-harm risk, and is restricting repeat medications for high-risk patients; these changes have been escalated to the ICB. (AI summary)
Addison House Health Centre has reviewed and updated its prescribing policy, enhanced IT system alerts related to self-harm risk, and is restricting repeat medications for high-risk patients; these changes have been escalated to the ICB. (AI summary)
View full response
Addison House & Barbara Castle Surgery
Web site: www.addison-surgery.nhs.uk
Addison House Health Centre Hamstel Road Harlow Essex CM20 1DS Barbara Castle Health Centre Broadley Road Harlow Essex CM19 5SJ
Partners:
03 November 2025
Prevention of Future Deaths Report (Regulation 28)
HM Area Coroner for Essex Sean Horstead Seax House Essex County Council Victoria Road South Chelmsford CM1 1LX
Re: Prevention of Future Deaths Report (Regulation 28) In the matter of: Late Mark Smith, Date of Death: 5/3/24 Coroner's Area: Essex
Thank you for your Report of 24/9/25 concerning the tragic death of Mark Smith. We extend our sincere condolences to his family and friends.
We acknowledge the profound seriousness of this matter and appreciate the concerns you have raised. We are committed to learning from this event and implementing robust changes to minimise the risk of such a tragedy occurring in the future.
This letter constitutes our formal response, as required within 56 days, detailing the actions we have taken and propose to take.
Response to Matters of Concern:
We address each of your specific concerns as follows:
Evidence was received from two GP Partners at Mr Smith’s GP Practice. Both GPs confirmed that at the time of Mr Smith’s involvement with the
Addison House & Barbara Castle Surgery
Practice continuing up to and including the date of the inquest, there continued to be no system, policy or process in place, to ensure that vulnerable patients with a history of addiction and/or self-harm and/or suicidal ideation and/or prescription medication overdose received or receive appropriate medication reviews to consider the frequency and volume of repeat prescribed medication.
There were safety provisions within the Practice’s repeat prescribing policy at the time of late Mark Smith’s death with multiple documented restrictions of inappropriate high risk medication requests by Mr Smith.
The Practice has updated and strengthened the risk assessment provisions of repeat prescribing for identified patients with self-harm or suicide risk as well as monitoring of same with enhanced medication reviews/risk assessments.
It was conceded, accordingly, that there was - and remained - no policy or procedure in place to mitigate the clear risk involved in GPs prescribing unnecessarily excessive quantities of (potentially dangerous) prescription medication (at inappropriate frequency) to a clearly vulnerable cohort of patients, and therefore no policy or procedure is in place to minimise the danger of stockpiling of such medications and the concomitant risk of potentially fatal, (advertent or inadvertent), misuse of such medication.
There were safety provisions within the Practice’s repeat prescribing policy at the time of late Mark Smith’s death.
The Practice has implemented changes to strengthen the risk assessment provisions of the repeat prescribing policy as well as monitoring of same.
Summary of Actions Taken –
The following actions have been undertaken:
Immediate High-Risk Patient Review: A full audit of all patients registered at Addison House Surgery, coded at risk of self-harm/suicide and on repeat medications. Identified patients have had medication/risk reviews by the pharmacists with restriction of repeat medications to seven-day periods. Medication Safety Policy Enhancement: A comprehensive review and update of our Polypharmacy and High-Risk Prescribing Policy undertaken with two core prescribing updates – 1-Pharmacists to review all future correspondence received at the Surgery with identified risk of self-harm/suicide - high risk medications to be reduced to seven-day supply periods. 2 -Low risk patients to remain on 6-monthly medication reviews– high risk patients to be reviewed 3 monthly or sooner if deemed necessary by clinician until the risk is de-escalated by the mental health team.
Addison House & Barbara Castle Surgery
We have conducted an urgent review of our IT system's safety alerts. We have enhanced the triggers for alerts related to self-harm and suicide risk with high level reminders to be applied to all identified patients’ records.
Governance Oversight: This incident and the associated action plans have been escalated to the Hertfordshire and West Essex ICB (integrated care board) Patient Safety team for ongoing monitoring.
We have shared the learning from this case with our local healthcare system, including other GP practices (within our primary care network – Harlow North) and community clinicians affiliated to the Surgery (via multidisciplinary team meeting), to promote wider improvement.
We are deeply sorry for the failings in the late Mark Smith’s care. We assure you that we have treated your report with the utmost seriousness and are committed to delivering sustainable change to enhance patient safety.
GP Partner Addison House Surgery Hamstel Road Harlow CM20 1DS
---
cc:
· The Chief Coroner · Chair of the Local Clinical Commissioning Group/Integrated Care Board · Care Quality Commission (CQC)
Addison House Surgery
Web site: www.addison-surgery.nhs.uk
Addison House Health Centre Hamstel Road Harlow Essex CM20 1DS Barbara Castle Health Centre Broadley Road Harlow Essex CM19 5SJ
Partners:
03 November 2025
Prevention of Future Deaths Report (Regulation 28)
HM Area Coroner for Essex Sean Horstead Seax House Essex County Council Victoria Road South Chelmsford CM1 1LX
Re: Prevention of Future Deaths Report (Regulation 28) In the matter of: Late Mark Smith, Date of Death: 5/3/24 Coroner's Area: Essex
Thank you for your Report of 24/9/25 concerning the tragic death of Mark Smith. We extend our sincere condolences to his family and friends.
We acknowledge the profound seriousness of this matter and appreciate the concerns you have raised. We are committed to learning from this event and implementing robust changes to minimise the risk of such a tragedy occurring in the future.
This letter constitutes our formal response, as required within 56 days, detailing the actions we have taken and propose to take.
Response to Matters of Concern:
We address each of your specific concerns as follows:
Evidence was received from two GP Partners at Mr Smith’s GP Practice. Both GPs confirmed that at the time of Mr Smith’s involvement with the
Addison House & Barbara Castle Surgery
Practice continuing up to and including the date of the inquest, there continued to be no system, policy or process in place, to ensure that vulnerable patients with a history of addiction and/or self-harm and/or suicidal ideation and/or prescription medication overdose received or receive appropriate medication reviews to consider the frequency and volume of repeat prescribed medication.
There were safety provisions within the Practice’s repeat prescribing policy at the time of late Mark Smith’s death with multiple documented restrictions of inappropriate high risk medication requests by Mr Smith.
The Practice has updated and strengthened the risk assessment provisions of repeat prescribing for identified patients with self-harm or suicide risk as well as monitoring of same with enhanced medication reviews/risk assessments.
It was conceded, accordingly, that there was - and remained - no policy or procedure in place to mitigate the clear risk involved in GPs prescribing unnecessarily excessive quantities of (potentially dangerous) prescription medication (at inappropriate frequency) to a clearly vulnerable cohort of patients, and therefore no policy or procedure is in place to minimise the danger of stockpiling of such medications and the concomitant risk of potentially fatal, (advertent or inadvertent), misuse of such medication.
There were safety provisions within the Practice’s repeat prescribing policy at the time of late Mark Smith’s death.
The Practice has implemented changes to strengthen the risk assessment provisions of the repeat prescribing policy as well as monitoring of same.
Summary of Actions Taken –
The following actions have been undertaken:
Immediate High-Risk Patient Review: A full audit of all patients registered at Addison House Surgery, coded at risk of self-harm/suicide and on repeat medications. Identified patients have had medication/risk reviews by the pharmacists with restriction of repeat medications to seven-day periods. Medication Safety Policy Enhancement: A comprehensive review and update of our Polypharmacy and High-Risk Prescribing Policy undertaken with two core prescribing updates – 1-Pharmacists to review all future correspondence received at the Surgery with identified risk of self-harm/suicide - high risk medications to be reduced to seven-day supply periods. 2 -Low risk patients to remain on 6-monthly medication reviews– high risk patients to be reviewed 3 monthly or sooner if deemed necessary by clinician until the risk is de-escalated by the mental health team.
Addison House & Barbara Castle Surgery
We have conducted an urgent review of our IT system's safety alerts. We have enhanced the triggers for alerts related to self-harm and suicide risk with high level reminders to be applied to all identified patients’ records.
Governance Oversight: This incident and the associated action plans have been escalated to the Hertfordshire and West Essex ICB (integrated care board) Patient Safety team for ongoing monitoring.
We have shared the learning from this case with our local healthcare system, including other GP practices (within our primary care network – Harlow North) and community clinicians affiliated to the Surgery (via multidisciplinary team meeting), to promote wider improvement.
We are deeply sorry for the failings in the late Mark Smith’s care. We assure you that we have treated your report with the utmost seriousness and are committed to delivering sustainable change to enhance patient safety.
GP Partner Addison House Surgery Hamstel Road Harlow CM20 1DS
---
cc:
· The Chief Coroner · Chair of the Local Clinical Commissioning Group/Integrated Care Board · Care Quality Commission (CQC)
Addison House Surgery
Part of a Series
2 separate reports were issued from this inquest, each sent to different organisations.
-
2026-0205
Sent to: 1. Chief Executive Officer, Practice Plus Group, 3rd Floor, 5 Lloyd’s Avenue, London EC3N 3AEChief Executive Officer, Practice Plus Group, 3rd Floor, 5 Lloyd’s Avenue, London EC3N 3AE 2. Chief Executive Lewisham and Greenwich NHS Trust, University Hospital Lewisham, Lewisham High Street, London SE13 76LH 3. The Director at HMP Thameside, Griffin Manor Way, London, SW28 0FJ. 4. Director General/Chief Executive HM Prison and Probation Service (HMPPS), 102 Petty France, London, SW1H 9AJ. 1CORONER I am Jenny Goldring assistant coroner, for the coroner area of Inner London South 2CORONER’S L2. Chief Executive Lewisham and Greenwich NHS Trust, University Hospital Lewisham, Lewisham High Street, London SE13 76LH3. The Director at HMP Thameside, Griffin Manor Way, London, SW28 0FJ.4. Director General/Chief Executive HM Prison and Probation Service (HMPPS), 102 Petty France, London, SW1H 9AJ.SercoNo responses yet
This report (2025-0478) is shown above.
Sent To
- Addison House Surgery
Response Status
Linked responses
1 of 1
56-Day Deadline
19 Nov 2025
All responses received
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Report Sections
Investigation and Inquest
On 14th March 2024 I commenced an investigation into the death of Mark Alan SMITH, aged 50 years’. The investigation concluded at the end of the inquest on the 5th August 2025. The conclusion of the inquest was a Narrative Conclusion In the following terms: Mark Alan Smith took his own life, but the evidence does not establish to the required standard of proof his intent at that the time he consumed the fatal quantities of prescription medication and alcohol. The admitted failure of his GP Practice to review, adequately or at all, the clear risk involved in the continued prescribing of unnecessarily excessive quantities of sedative prescription medication in the context of Mr Smith’s extensive background of addiction and mental health issues, including anxiety and depression and a previous history of overdoses of prescribed medication, probably contributed more than minimally to the death.
Circumstances of the Death
Mark Alan Smith was found deceased on 5th March 2024 at his home address, 23 Church End, Harlow, Essex. He died following the ingestion of large quantities of prescription medication including Mirtazapine and Pregabalin together with a very significant quantity of alcohol. Crews from the East of England Ambulance Service Trust (EEAST) attended Mr Smith’s home for around two and a half hours from around 04.00 hours on the 4th March (following concerns raised by family members that he had taken an overdose of prescription drugs). An EEAST crew reattended for around twenty minutes on the afternoon of the same day after Essex Police contacted EEAST following a call from Mr Smith’s mother that he was threatening to take his own life. On neither occasion was Mr Smith taken to Hospital. The last contact with family members was between 18.00 and 19.00 hours on the 4th March. Mr Smith was found deceased the following morning by his son.
Similar PFD Reports
Reports sharing organisations, categories, or themes
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Responsibility for monitoring delivery of standards and quality
Mid Staffs Inquiry
GP oversight of specialist care
Ensure identified GP for children with deliberate harm concerns discharged from hospital.
Laming Inquiry
GP Continuity of Care Breakdown
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.